Genoway Stock

Genoway EBIT

The EBIT of Genoway (ALGEN.PA) as of Jul 15, 2026 is 1.81 M EUR. In the previous year, EBIT was 2.07 M EUR — a change of -12.25% (lower).

EBIT

1.81 MEUR

YoY

-12.25%

Last updated:

In 2026, Genoway's EBIT was 1.81 M EUR, a -12.25% increase from the 2.07 M EUR EBIT recorded in the previous year.

The Genoway EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M EUR)
Date
EBIT (M EUR)
Jan 1, 2020
-0.34 base
Jan 1, 2021
-0.44 base
Jan 1, 2022
0.95 base
Jan 1, 2023
2.07 base
Jan 1, 2024
1.81 base
Jan 1, 2025 (e)
0.62 base
Jan 1, 2026 (e)
0.41 base
Jan 1, 2027 (e)
1.44 base
YEAREBIT (M EUR)
2027 est 1.44
2026 est 0.41
2025 est 0.62
2024 1.81
2023 2.07
2022 0.95
2021 -0.44
2020 -0.34
2019 -0.57
2018 0.60
2017 0.75
2016 0.69
2015 0.38
2014 0.25
2013 0.18
2012 -0.44
2011 0.36
2010 0.71
2009 0.37
2008 -0.95
2007 -1.00
2006 -2.47
2005 -3.55
Access this data via the Eulerpool API

Genoway Revenue

Genoway Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
11.02 M EUR
-339,700.00 EUR
-687,300.00 EUR
Jan 1, 2021
14.02 M EUR
-438,200.00 EUR
-322,600.00 EUR
Jan 1, 2022
17.05 M EUR
949,800.00 EUR
777,800.00 EUR
Jan 1, 2023
20.05 M EUR
2.07 M EUR
1.57 M EUR
Jan 1, 2024
22.06 M EUR
1.81 M EUR
1.83 M EUR
Jan 1, 2025 (e)
22.76 M EUR
618,000.00 EUR
0.00 EUR
Jan 1, 2026 (e)
26.27 M EUR
412,000.00 EUR
0.00 EUR
Jan 1, 2027 (e)
32.96 M EUR
1.44 M EUR
894,544.70 EUR

Genoway Margins

Genoway stock margins

The Genoway margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Genoway. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Genoway.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
99.66 %
-3.08 %
-6.24 %
Jan 1, 2021
91.30 %
-3.13 %
-2.30 %
Jan 1, 2022
95.26 %
5.57 %
4.56 %
Jan 1, 2023
95.82 %
10.30 %
7.82 %
Jan 1, 2024
93.31 %
8.22 %
8.30 %
Jan 1, 2025 (e)
93.31 %
2.71 %
0.00 %
Jan 1, 2026 (e)
93.31 %
1.57 %
0.00 %
Jan 1, 2027 (e)
93.31 %
4.38 %
2.71 %

Genoway Stock analysis

What does Genoway do? Genoway SA is a biotechnology company based in Lyon, France. It was founded in 2002 by Pierre Cadinot. The company specializes in the production of genetically modified mice for disease research and the development of new therapies. The business model of Genoway is to provide customers with customized genetically modified mice. The company offers a wide range of services, from consulting during the design phase to the delivery of modified mice. The company also offers services in the field of cell culture and transgene expression. Genoway is divided into different divisions to meet specific customer needs. For example, there is the "Knockout Mice" division, which specializes in producing mice that lack a specific target gene. These mice are used to study the function of the missing gene in vivo. Another area of Genoway is the production of "humanized mouse models". These are mice in which human genes have been inserted to model specific human diseases or to test the efficacy of drugs. These humanized mice are an important part of drug research in the pharmaceutical industry. Genoway also offers services in the field of inducible expression. This involves triggering the expression of a target gene in vivo to study the effects of the protein. This technology is particularly useful in the research of diseases such as cancer, where certain genes are only active in specific cells. In addition to these specialized services, Genoway also offers a wide range of standard services, such as the creation of stable cell lines or transgene expression in various organs and tissues. Genoway is a leading company in the development of genetically modified models for the study of human diseases. The company works closely with its customers to develop customized solutions that meet the specific requirements of each project. With its divisions and services, it aims to support its customers in the development of new therapies and drugs. Genoway is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Genoway's EBIT

Genoway's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Genoway's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Genoway's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Genoway’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Genoway stock

EBIT of Genoway is 1.81 M EUR in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Genoway

All Key Metrics — Genoway